- Home
- EA vs A Comparison
EA vs A Comparison
Compare EA & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EA
- A
- Stock Information
- Founded
- EA 1982
- A 1999
- Country
- EA United States
- A United States
- Employees
- EA N/A
- A N/A
- Industry
- EA Computer Software: Prepackaged Software
- A Biotechnology: Laboratory Analytical Instruments
- Sector
- EA Technology
- A Industrials
- Exchange
- EA Nasdaq
- A Nasdaq
- Market Cap
- EA 41.4B
- A 37.5B
- IPO Year
- EA N/A
- A 1999
- Fundamental
- Price
- EA $167.97
- A $132.02
- Analyst Decision
- EA Buy
- A Buy
- Analyst Count
- EA 18
- A 17
- Target Price
- EA $165.59
- A $143.07
- AVG Volume (30 Days)
- EA 2.0M
- A 1.9M
- Earning Date
- EA 10-29-2024
- A 11-25-2024
- Dividend Yield
- EA 0.45%
- A 0.72%
- EPS Growth
- EA 7.92
- A 25.91
- EPS
- EA 3.89
- A 4.81
- Revenue
- EA $7,409,000,000.00
- A $6,497,000,000.00
- Revenue This Year
- EA $4.88
- A N/A
- Revenue Next Year
- EA $5.86
- A $5.30
- P/E Ratio
- EA $43.15
- A $27.42
- Revenue Growth
- EA N/A
- A N/A
- 52 Week Low
- EA $124.92
- A $123.48
- 52 Week High
- EA $167.76
- A $155.35
- Technical
- Relative Strength Index (RSI)
- EA 77.57
- A 46.50
- Support Level
- EA $159.38
- A $124.89
- Resistance Level
- EA $164.42
- A $143.07
- Average True Range (ATR)
- EA 2.96
- A 3.43
- MACD
- EA 0.78
- A -0.37
- Stochastic Oscillator
- EA 99.49
- A 39.22
About EA Electronic Arts Inc.
Electronic Arts is one of the world's largest third-party video game publishers and has transitioned from a console-based video game publisher to the one of the largest publishers on consoles, PC, and mobile. The firm owns number of large franchises, including Madden, EA Sports FC (formerly FIFA), Battlefield, Apex Legends, Mass Effect, Dragon's Age, and Need for Speed.
About A Agilent Technologies Inc.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.